| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Loss to care and death before antiretroviral therapy in Durban, South Africa.
|
J Acquir Immune Defic Syndr
|
2009
|
5.40
|
|
2
|
Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa.
|
Clin Infect Dis
|
2010
|
3.96
|
|
3
|
HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness.
|
Clin Infect Dis
|
2009
|
3.89
|
|
4
|
CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment.
|
J Acquir Immune Defic Syndr
|
2006
|
3.39
|
|
5
|
Scaling up antiretroviral therapy in South Africa: the impact of speed on survival.
|
J Infect Dis
|
2008
|
2.96
|
|
6
|
Routine voluntary HIV testing in Durban, South Africa: the experience from an outpatient department.
|
J Acquir Immune Defic Syndr
|
2007
|
2.91
|
|
7
|
Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parameters.
|
J Virol
|
2010
|
1.81
|
|
8
|
The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire.
|
Antivir Ther
|
2007
|
1.68
|
|
9
|
Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India.
|
Clin Infect Dis
|
2010
|
1.55
|
|
10
|
Influence of Gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C.
|
J Virol
|
2011
|
1.45
|
|
11
|
Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy.
|
AIDS
|
2007
|
1.34
|
|
12
|
Loss to follow-up and mortality among HIV-infected people co-infected with TB at ART initiation in Durban, South Africa.
|
J Acquir Immune Defic Syndr
|
2012
|
1.17
|
|
13
|
Impact of select immunologic and virologic biomarkers on CD4 cell count decrease in patients with chronic HIV-1 subtype C infection: results from Sinikithemba Cohort, Durban, South Africa.
|
Clin Infect Dis
|
2009
|
1.02
|
|
14
|
Estimates of opportunistic infection incidence or death within specific CD4 strata in HIV-infected patients in Abidjan, Côte d'Ivoire: impact of alternative methods of CD4 count modelling.
|
Eur J Epidemiol
|
2007
|
1.01
|
|
15
|
HIV-free survival and morbidity among formula-fed infants in a prevention of mother-to-child transmission of HIV program in rural Haiti.
|
AIDS Res Ther
|
2011
|
0.85
|
|
16
|
Effectiveness of Centers for Disease Control and Prevention recommendations for outcomes of acute otitis media.
|
Pediatrics
|
2006
|
0.84
|
|
17
|
Association of IL-10-promoter genetic variants with the rate of CD4 T-cell loss, IL-10 plasma levels, and breadth of cytotoxic T-cell lymphocyte response during chronic HIV-1 infection.
|
Clin Infect Dis
|
2011
|
0.80
|
|
18
|
Assessing the performance of a computer-based policy model of HIV and AIDS.
|
PLoS One
|
2010
|
0.79
|
|
19
|
Drug-resistant tuberculosis among HIV-infected patients starting antiretroviral therapy in Durban, South Africa.
|
PLoS One
|
2012
|
0.75
|